FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366998786> ?p ?o ?g. }

• W4366998786 abstract "Enzyme replacement therapy with olipudase alfa, a recombinant human acid sphingomyelinase (rhASM), is indicated for non-central nervous system manifestations of acid sphingomyelinase deficiency (ASMD) in children and adults. An ongoing, open-label, long-term study (NCT02004704) assessed the safety and efficacy of olipudase alfa in 5 adults with ASMD.After 6.5 years of treatment, there were no discontinuations, no olipudase-alfa-related serious adverse events, and no new safety signals compared to earlier assessments. Most treatment-emergent adverse events were mild in intensity (1742/1766, 98.6%). Among treatment-related adverse events (n = 657), more than half were considered infusion-associated reactions (n = 403, 61.3%) such as headache, nausea, abdominal pain, arthralgia, pyrexia, and fatigue. No patient developed neutralizing anti-drug antibodies to cellular uptake, and there were no clinically significant adverse changes in vital signs, hematology, or cardiac safety parameters. Improvements (decreases) in spleen and liver volumes progressed through 6.5 years (mean changes from baseline of -59.5% and -43.7%, respectively). There was a mean increase in diffusing capacity of the lung for carbon monoxide from baseline of 55.3%, accompanied by improvements in interstitial lung disease parameters. Lipid profiles at baseline indicated dyslipidemia. All patients had sustained decreases in pro-atherogenic lipid levels and increases in anti-atherogenic lipid levels following olipudase alfa treatment.Olipudase alfa is the first disease-specific treatment for ASMD. This study demonstrates that long-term treatment with olipudase alfa is well-tolerated and is associated with sustained improvements in relevant disease clinical measures. NCT02004704 registered 26 November 2013, https://clinicaltrials.gov/ct2/show/NCT02004704?term=NCT02004704&draw=2&rank=1 ." @default.
• W4366998786 created "2023-04-27" @default.
• W4366998786 creator A5007779785 @default.
• W4366998786 creator A5008403948 @default.
• W4366998786 creator A5016091950 @default.
• W4366998786 creator A5021956757 @default.
• W4366998786 creator A5072862654 @default.
• W4366998786 creator A5073345449 @default.
• W4366998786 creator A5082859823 @default.
• W4366998786 date "2023-04-25" @default.
• W4366998786 modified "2023-09-30" @default.
• W4366998786 title "Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults" @default.
• W4366998786 cites W175660244 @default.
• W4366998786 cites W1781015672 @default.
• W4366998786 cites W1960122038 @default.
• W4366998786 cites W1993045679 @default.
• W4366998786 cites W1994435180 @default.
• W4366998786 cites W2001038217 @default.
• W4366998786 cites W2013549544 @default.
• W4366998786 cites W2023625342 @default.
• W4366998786 cites W2025782555 @default.
• W4366998786 cites W2028216720 @default.
• W4366998786 cites W2067885092 @default.
• W4366998786 cites W2083139822 @default.
• W4366998786 cites W2104607370 @default.
• W4366998786 cites W2120034344 @default.
• W4366998786 cites W2124879124 @default.
• W4366998786 cites W2125078269 @default.
• W4366998786 cites W2137215672 @default.
• W4366998786 cites W2141922649 @default.
• W4366998786 cites W2358339915 @default.
• W4366998786 cites W2381702116 @default.
• W4366998786 cites W2513957909 @default.
• W4366998786 cites W2562918265 @default.
• W4366998786 cites W2591036609 @default.
• W4366998786 cites W2781992688 @default.
• W4366998786 cites W2796313264 @default.
• W4366998786 cites W2913340875 @default.
• W4366998786 cites W3037819515 @default.
• W4366998786 cites W3154260989 @default.
• W4366998786 cites W3160688985 @default.
• W4366998786 cites W3209212701 @default.
• W4366998786 cites W4224944608 @default.
• W4366998786 cites W4311399024 @default.
• W4366998786 doi "https://doi.org/10.1186/s13023-023-02700-x" @default.
• W4366998786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37098529" @default.
• W4366998786 hasPublicationYear "2023" @default.
• W4366998786 type Work @default.
• W4366998786 citedByCount "1" @default.
• W4366998786 countsByYear W43669987862023 @default.
• W4366998786 crossrefType "journal-article" @default.
• W4366998786 hasAuthorship W4366998786A5007779785 @default.
• W4366998786 hasAuthorship W4366998786A5008403948 @default.
• W4366998786 hasAuthorship W4366998786A5016091950 @default.
• W4366998786 hasAuthorship W4366998786A5021956757 @default.
• W4366998786 hasAuthorship W4366998786A5072862654 @default.
• W4366998786 hasAuthorship W4366998786A5073345449 @default.
• W4366998786 hasAuthorship W4366998786A5082859823 @default.
• W4366998786 hasBestOaLocation W43669987861 @default.
• W4366998786 hasConcept C126322002 @default.
• W4366998786 hasConcept C197934379 @default.
• W4366998786 hasConcept C2778163477 @default.
• W4366998786 hasConcept C2779134260 @default.
• W4366998786 hasConcept C2779969927 @default.
• W4366998786 hasConcept C2780580376 @default.
• W4366998786 hasConcept C2781457462 @default.
• W4366998786 hasConcept C535046627 @default.
• W4366998786 hasConcept C61322309 @default.
• W4366998786 hasConcept C71924100 @default.
• W4366998786 hasConcept C90924648 @default.
• W4366998786 hasConcept C98274493 @default.
• W4366998786 hasConceptScore W4366998786C126322002 @default.
• W4366998786 hasConceptScore W4366998786C197934379 @default.
• W4366998786 hasConceptScore W4366998786C2778163477 @default.
• W4366998786 hasConceptScore W4366998786C2779134260 @default.
• W4366998786 hasConceptScore W4366998786C2779969927 @default.
• W4366998786 hasConceptScore W4366998786C2780580376 @default.
• W4366998786 hasConceptScore W4366998786C2781457462 @default.
• W4366998786 hasConceptScore W4366998786C535046627 @default.
• W4366998786 hasConceptScore W4366998786C61322309 @default.
• W4366998786 hasConceptScore W4366998786C71924100 @default.
• W4366998786 hasConceptScore W4366998786C90924648 @default.
• W4366998786 hasConceptScore W4366998786C98274493 @default.
• W4366998786 hasFunder F4320333587 @default.
• W4366998786 hasIssue "1" @default.
• W4366998786 hasLocation W43669987861 @default.
• W4366998786 hasLocation W43669987862 @default.
• W4366998786 hasLocation W43669987863 @default.
• W4366998786 hasOpenAccess W4366998786 @default.
• W4366998786 hasPrimaryLocation W43669987861 @default.
• W4366998786 hasRelatedWork W1980872763 @default.
• W4366998786 hasRelatedWork W2057659215 @default.
• W4366998786 hasRelatedWork W2363890076 @default.
• W4366998786 hasRelatedWork W2380979459 @default.
• W4366998786 hasRelatedWork W2384102814 @default.
• W4366998786 hasRelatedWork W243857094 @default.
• W4366998786 hasRelatedWork W2888625382 @default.
• W4366998786 hasRelatedWork W2956249214 @default.
• W4366998786 hasRelatedWork W3137663875 @default.
• W4366998786 hasRelatedWork W4366998786 @default.

• next